April 16, 2021 Media Coverage from ARCH Venture Partners | Share ARCH Venture Partners Named to Forbes’ Midas List 2021
April 15, 2021 Portfolio News from ARCH Venture Partners | Share ‘One Billion Doses On Day One’: Vaccine Company Resilience Claims World-Changing Innovation
April 13, 2021 Portfolio News from ARCH Venture Partners | Share Lilly, ARCH join Deerfield in backing new gene therapy biotech Jaguar
April 6, 2021 Media Coverage from ARCH Venture Partners | Share Two ARCH Team Members named to Endpoints 20 Under 40
March 26, 2021 Portfolio News from ARCH Venture Partners | Share GSK and Vir seek emergency use of COVID-19 therapy in United States
March 25, 2021 Portfolio News from ARCH Venture Partners | Share National Resilience, months after launching with $800M, snags Sanofi biomanufacturing plant
February 19, 2021 Portfolio News from ARCH Venture Partners | Share 908 Devices Stock More Than Doubles in Market Debut
February 12, 2021 Portfolio News from ARCH Venture Partners | Share Encodia Closes $75M Series C Financing
February 4, 2021 Portfolio News from ARCH Venture Partners | Share Sana Snags $587.5M IPO to Catapult Cell Therapies into the Clinic
January 28, 2021 ARCH News from ARCH Venture Partners | Share ARCH Venture Partners Announces New $1.85 Billion Fund to Create and Fund Early Stage Biotechnology Companies
December 1, 2020 Portfolio News from ARCH Venture Partners | Share Resilience – Raging at the Pandemic, a VC raises $800M for a Company That Aims to Transform Biotech Manufacturing
